As a group, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.54 earnings per share for the current year.

Source: https://www.etfdailynews.com/2023/01/20/comerica-bank-cuts-stock-holdings-in-pediatrix-medical-group-inc-nysemd/

Finally, Captrust Financial Advisors increased its stake in shares of Pediatrix Medical Group by 100.4% in the 2nd quarter.

Source: https://www.etfdailynews.com/2023/02/11/prudential-financial-inc-reduces-holdings-in-pediatrix-medical-group-inc-nysemd/

Royal Bank of Canada lifted its stake in shares of Pediatrix Medical Group by 97.3% in the third quarter.

Source: https://www.etfdailynews.com/2023/08/26/mitsubishi-ufj-trust-banking-corp-has-274000-stock-holdings-in-pediatrix-medical-group-inc-nysemd/

SVB Leerink decreased their price target on Pediatrix Medical Group from $20.00 to $16.00 and set a “market perform” rating for the company in a report on Friday, November 4th.

Source: https://www.etfdailynews.com/2023/01/28/pediatrix-medical-group-inc-nysemd-shares-sold-by-sg-americas-securities-llc/

Tower Research Capital LLC TRC grew its holdings in shares of Pediatrix Medical Group by 123.1% in the 3rd quarter.

Source: https://www.etfdailynews.com/2023/02/26/exoduspoint-capital-management-lp-has-802000-stock-holdings-in-pediatrix-medical-group-inc-nysemd/